Victor Huang, M.D.
Associate Professor
To see if Victor Huang is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Phone: 916-734-6111
UC Davis Medical Group - Davis (West Covell Boulevard)
UC Davis Medical Group - Davis (West Covell Boulevard)
2660 W. Covell Blvd.
Davis, CA 95616
Additional Numbers
Physician Referrals
Philosophy of Care
Compassionate care centered on the patient experience is at the center of my personal mission. There are some conditions that are easily diagnosed and treated, and others that are complicated and chronic. In either case, my goal is to guide each patient through their personal journey by leveraging my own training and experience as well as the resources available via my regional, national, and international colleagues.
Clinical Interests
Dr. Huang has a special clinical interest in vitiligo, an autoimmune depigmenting condition of the skin, and inflammatory conditions of the skin. He also maintains an interest in drug reactions related to cancer therapies, and is the Director of Phototherapy and Vice Chair of Clinical Research at UC Davis.
Research/Academic Interests
Dr. Huang's research focuses on the clinical, epidemiologic, and translational understanding of vitiligo, an autoimmune condition of the skin. To that end, he has established collaborations to investigate novel technologies for the evaluation and treatment of vitiligo, and has been involved with clinical trials. In addition, he is active in understanding dermatologic sequellae of cytotoxic chemotherapies and targeted therapies used to treat cancer.
Division
Dermatology
Undergraduate School
A.B., Harvard College, Cambridge MA 2003
Medical School
M.D., UC San Francisco School of Medicine, San Francisco CA 2008
Internship
Internal Medicine, University of Chicago, Chicago IL 2008-2009
Residency
Dermatology, Washington University in St. Louis, St. Louis MO 2009-2012
Fellowship
Dermatology, Brigham and Women's Hospital, Boston MA 2012-2014
Academic Dermatology Leadership Program American Academy of Dermatology, 2016
EADV Educational FellowshipEuropean Academy of Dermatology and Venereology, 2014
NIH Loan Repayment Program, 2013
World Congress Travel Fellowship Society for Investigative Dermatology, 2012
Scholarship for Excellent Academic Achievement North American Taiwanese Medical Association, 2011
Renert-Yuval Y, Desai S, Huang V, Walsh S, Rosmarin D, Silverberg N. A Review of the Vitiligo Literature to Standardize Expression of Disease Severity. J Drugs Dermatol. 2024; 23(10): 842-846.
Hamzavi IH, Ganesan AK, Mahmoud BH, Weiss E, Ahmed AM, Robinson D, Goldman MP, Munavalli G, Kahn SA, Huang V, Waibel J, Desai A, Elbuluk N, Desai S, Pandya AG. Effective and durable repigmentation for stable vitiligo: a randomized withinsubject controlled trial assessing treatment with autologous skin cell suspension transplantation. J Am Acad Dermatol. 2024.
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. J Immunother Cancer. 2024; 12(4).
Renert-Yuval Y, Ezzedine K, Grimes P, Rosmarin D, Eichenfield LF, Castelo-Soccio L, Huang V, Desai SR, Walsh S, Silverberg JI, Paller AS, Rodrigues M, Weingarten M, Narla S, Gardner J, Siegel M, Ibad S, Silverberg NB. Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients. JAMA Dermatol. 2024; 160(4):453-461.
Firoz WA, Sen F, Kiuru M, Huang V, Riess JW. A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis. Clin Lung Cancer. 2024; 25(4):380-383.
Sachar M, Lin BM, Wong V, Li W, Huang V, Harris J, Ezzedine K, Cho E, Qureshi AA. Association between acetaminophen use and vitiligo in US women and men. Australas J Dermatol. 2023; 64(4): e348-e351.
Kim-Lim P, Wennberg E, Van Noord M, Hastings LW, Sullivan SD, Huang V, Wu PA. Systematic Review of Systemic Corticosteroid Effects on Patch Testing (published Oct 2022). Dermatitis: contact, atopic, occupational, drug. 2022; 33(6): 405-410.
Liu KX, Huang V, Chen CA, Elco CP, Chen ST, Stern RS, Wu PA. Longitudinal multicentre retrospective cohort study of treatment outcomes in extramammary Paget disease. The British journal of dermatology. 2021; 85(1): 219-221.
Wennberg E, Richards PQ, Bain PA, Huang V, Sullivan SD, Maverakis EM, Molina GE, Wu PA. Topical treatments for early-stage mycosis fungoides using Grading Recommendations Assessment, Development and Evaluation (GRADE) criteria: A systematic review. JAAD international. 2021; 3: 26-41.
Mobasher P, Guerra R, Jiayang Li S, Frangos J, Ganesan AK, Huang V. Open Label Pilot Study of 2% Tofacitinib for the Treatment of Refractory Vitiligo. The British journal of dermatology. 2019; 182(4):1047-1049.